This site is intended for healthcare professionals only
LoginRegister

Medicine Dialogues

Baxdrostat Significantly Lowers Blood Pressure in Resistant Hypertension in Phase 3 trial

Baxdrostat Significantly Lowers Blood Pressure in Resistant Hypertension in Phase 3 trial

AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary endpoints in the BaxHTN Phase III...
View All

Latest News and Guidelines

Diet, Income, and City Living Raise Antibiotic Resistance and Mortality Risk: Study Finds

Diet, Income, and City Living Raise Antibiotic Resistance and Mortality Risk: Study Finds

Type 2 diabetes

Fasting twice a week could be a game-changer for type 2 diabetes: Study

Rheumatoid Arthritis-Linked Lung Disease Significantly Raises Risk of Death, Finds Study

Rheumatoid Arthritis-Linked Lung Disease Significantly Raises Risk of Death, Finds Study

GLP-1 Receptor Agonists Promising in Managing Idiopathic Intracranial Hypertension: JAMA Study

GLP-1 Receptor Agonists Promising in Managing Idiopathic Intracranial Hypertension: JAMA Study

Late eating is associated with impaired glucose metabolism, suggests study

Late eating is associated with impaired glucose metabolism, suggests study

Ambroxol Engages Target in Parkinsons Dementia but Shows No Cognitive Benefit: Study

Ambroxol Engages Target in Parkinson's Dementia but Shows No Cognitive Benefit: Study

View All
X